ResearchLenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial
ResearchCase report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML
ResearchASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine
ResearchEthnic disparities in survival of adult B-cell acute lymphoblastic leukemia in modern era - a SEER analysis